{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:05:24Z","timestamp":1786982724133,"version":"build-2736575974"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"GSK"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s40121-024-00924-3","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T10:54:40Z","timestamp":1709636080000},"page":"447-461","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The Impact of the COVID-19 Pandemic on the Incidence of Herpes Zoster: A Narrative Literature Review"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8412-307X","authenticated-orcid":false,"given":"Raunak","family":"Parikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3076-5701","authenticated-orcid":false,"given":"Mitra","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7423-0111","authenticated-orcid":false,"given":"Desmond","family":"Curran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9830-6299","authenticated-orcid":false,"given":"Robyn","family":"Widenmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,5]]},"reference":[{"issue":"RR-5","key":"924_CR1","first-page":"1","volume":"57","author":"R Harpaz","year":"2008","unstructured":"Harpaz R, Ortega-Sanchez IR, Seward JF, Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR-5):1\u2013CE4.","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"924_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1056\/NEJMcp1302674","volume":"369","author":"JI Cohen","year":"2013","unstructured":"Cohen JI. Clinical practice: herpes zoster. N Engl J Med. 2013;369(3):255\u201363. https:\/\/doi.org\/10.1056\/NEJMcp1302674.","journal-title":"N Engl J Med"},{"issue":"11","key":"924_CR3","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.4065\/82.11.1341","volume":"82","author":"BP Yawn","year":"2007","unstructured":"Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82(11):1341\u20139. https:\/\/doi.org\/10.4065\/82.11.1341.","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"924_CR4","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S1474-4422(09)70134-6","volume":"8","author":"D Gilden","year":"2009","unstructured":"Gilden D, Cohrs RJ, Mahalingam R, Nagel MA. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol. 2009;8(8):731\u201340. https:\/\/doi.org\/10.1016\/S1474-4422(09)70134-6.","journal-title":"Lancet Neurol"},{"issue":"5","key":"924_CR5","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1161\/STROKEAHA.120.030630","volume":"52","author":"MN Bahouth","year":"2021","unstructured":"Bahouth MN, Venkatesan A. Acute viral illnesses and ischemic stroke: pathophysiological considerations in the era of the COVID-19 pandemic. Stroke. 2021;52(5):1885\u201394. https:\/\/doi.org\/10.1161\/STROKEAHA.120.030630.","journal-title":"Stroke"},{"issue":"1","key":"924_CR6","first-page":"123","volume":"17","author":"M Tsatsos","year":"2022","unstructured":"Tsatsos M, Athanasiadis I, Myrou A, Saleh GM, Ziakas N. Herpes zoster ophthalmicus: a devastating disease coming back with vengeance or finding its nemesis? J Ophthalmic Vis Res. 2022;17(1):123\u20139. https:\/\/knepublishing.com\/index.php\/JOVR\/article\/view\/10177.","journal-title":"J Ophthalmic Vis Res"},{"issue":"6","key":"924_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-004833","volume":"4","author":"K Kawai","year":"2014","unstructured":"Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4(6):e004833. https:\/\/doi.org\/10.1136\/bmjopen-2014-004833.","journal-title":"BMJ Open"},{"issue":"2","key":"924_CR8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/cid\/ciw296","volume":"63","author":"K Kawai","year":"2016","unstructured":"Kawai K, Yawn BP, Wollan P, Harpaz R. Increasing incidence of herpes zoster over a 60-year period from a population-based study. Clin Infect Dis. 2016;63(2):221\u20136. https:\/\/doi.org\/10.1093\/cid\/ciw296.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"924_CR9","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/cid\/ciy953","volume":"69","author":"R Harpaz","year":"2019","unstructured":"Harpaz R, Leung JW. The epidemiology of herpes zoster in the United States during the era of varicella and herpes zoster vaccines: changing patterns among older adults. Clin Infect Dis. 2019;69(2):341\u20134. https:\/\/doi.org\/10.1093\/cid\/ciy953.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"924_CR10","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.bpa.2021.02.003","volume":"35","author":"AD Kaye","year":"2021","unstructured":"Kaye AD, Spence AL, Mayerle M, et\u00a0al. Impact of COVID-19 infection on the cardiovascular system: an evidence-based analysis of risk factors and outcomes. Best Pract Res Clin Anaesthesiol. 2021;35(3):437\u201348. https:\/\/doi.org\/10.1016\/j.bpa.2021.02.003.","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"8","key":"924_CR11","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","volume":"324","author":"WJ Wiersinga","year":"2020","unstructured":"Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782\u201393. https:\/\/doi.org\/10.1001\/jama.2020.12839.","journal-title":"JAMA"},{"key":"924_CR12","doi-asserted-by":"publisher","first-page":"1180252","DOI":"10.3389\/fpsyt.2023.1180252","volume":"14","author":"L Jain","year":"2023","unstructured":"Jain L, Bhivandkar S, Baqir H, et\u00a0al. Beyond physical health: the role of psychosocial challenges and stigma in tackling the COVID-19 pandemic\u2014a scoping review. Front Psychiatry. 2023;14:1180252. https:\/\/doi.org\/10.3389\/fpsyt.2023.1180252.","journal-title":"Front Psychiatry"},{"issue":"1","key":"924_CR13","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1080\/07853890.2021.2009128","volume":"53","author":"MOC Ota","year":"2021","unstructured":"Ota MOC, Badur S, Romano-Mazzotti L, Friedland LR. Impact of COVID-19 pandemic on routine immunization. Ann Med. 2021;53(1):2286\u201397. https:\/\/doi.org\/10.1080\/07853890.2021.2009128.","journal-title":"Ann Med"},{"issue":"29","key":"924_CR14","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1016\/j.vaccine.2021.05.050","volume":"39","author":"Y Aizawa","year":"2021","unstructured":"Aizawa Y, Katsuta T, Sakiyama H, Tanaka-Taya K, Moriuchi H, Saitoh A. Changes in childhood vaccination during the coronavirus disease 2019 pandemic in Japan. Vaccine. 2021;39(29):4006\u201312. https:\/\/doi.org\/10.1016\/j.vaccine.2021.05.050.","journal-title":"Vaccine"},{"issue":"23","key":"924_CR15","doi-asserted-by":"publisher","first-page":"840","DOI":"10.15585\/mmwr.mm7023a2","volume":"70","author":"B Patel Murthy","year":"2021","unstructured":"Patel Murthy B, Zell E, Kirtland K, et\u00a0al. Impact of the COVID-19 pandemic on administration of selected routine childhood and adolescent vaccinations \u2014 10 U.S. jurisdictions, March\u2013September 2020. MMWR Morb Mortal Wkly Rep. 2021;70(23):840\u20135. https:\/\/doi.org\/10.15585\/mmwr.mm7023a2.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"25","key":"924_CR16","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1016\/j.vaccine.2021.04.046","volume":"39","author":"MF Silveira","year":"2021","unstructured":"Silveira MF, Tonial CT, Maranh\u00e3o AGK, et\u00a0al. Missed childhood immunizations during the COVID-19 pandemic in Brazil: analyses of routine statistics and of a national household survey. Vaccine. 2021;39(25):3404\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2021.04.046.","journal-title":"Vaccine"},{"key":"924_CR17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.15585\/mmwr.mm7007a4","volume":"70","author":"K Hong","year":"2021","unstructured":"Hong K, Zhou F, Tsai Y, et\u00a0al. Decline in receipt of vaccines by Medicare beneficiaries during the COVID-19 pandemic \u2014 United States, 2020. MMWR Morb Mortal Wkly Rep. 2021;70:245\u20139. https:\/\/doi.org\/10.15585\/mmwr.mm7007a4.","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"924_CR18","unstructured":"National Institute for Public Health and the Environment. The National Immunisation Programme in the Netherlands: Surveillance and developments in 2019\u20132020. RIVM Report 2020\u20130077. https:\/\/www.rivm.nl\/bibliotheek\/rapporten\/2020-0077.pdf. Accessed 20 Feb 2024."},{"key":"924_CR19","unstructured":"Centers for Disease Control and Prevention. Vaccination Coverage among Adults in the United States, National Health Interview Survey, 2021. https:\/\/www.cdc.gov\/vaccines\/imz-managers\/coverage\/adultvaxview\/pubs-resources\/vaccination-coverage-adults-2021.html#print. Accessed 8 Nov 2023."},{"issue":"5","key":"924_CR20","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1093\/cid\/ciaa1728","volume":"72","author":"Z Amin-Chowdhury","year":"2021","unstructured":"Amin-Chowdhury Z, Aiano F, Mensah A, et\u00a0al. Impact of the coronavirus disease 2019 (COVID-19) pandemic on invasive pneumococcal disease and risk of pneumococcal coinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): prospective national cohort study, England. Clin Infect Dis. 2021;72(5):e65\u201375. https:\/\/doi.org\/10.1093\/cid\/ciaa1728.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"924_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-055575","volume":"11","author":"KF Chan","year":"2021","unstructured":"Chan KF, Ma TF, Ip MS, Ho PL. Invasive pneumococcal disease, pneumococcal pneumonia and all-cause pneumonia in Hong Kong during the COVID-19 pandemic compared with the preceding 5 years: a retrospective observational study. BMJ Open. 2021;11(10):e055575. https:\/\/doi.org\/10.1136\/bmjopen-2021-055575.","journal-title":"BMJ Open"},{"key":"924_CR22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ijid.2021.08.060","volume":"111","author":"KKT Dirkx","year":"2021","unstructured":"Dirkx KKT, Mulder B, Post AS, et\u00a0al. The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained. Int J Infect Dis. 2021;111:196\u2013203. https:\/\/doi.org\/10.1016\/j.ijid.2021.08.060.","journal-title":"Int J Infect Dis"},{"issue":"10","key":"924_CR23","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.jiac.2021.06.021","volume":"27","author":"T Kitano","year":"2021","unstructured":"Kitano T. The estimated burden of 15 vaccine-preventable diseases from 2008 to 2020 in Japan: a transition by the COVID-19 pandemic. J Infect Chemother. 2021;27(10):1482\u20138. https:\/\/doi.org\/10.1016\/j.jiac.2021.06.021.","journal-title":"J Infect Chemother"},{"key":"924_CR24","unstructured":"World Health Organization. Global Influenza Programme. https:\/\/www.who.int\/tools\/flunet. Accessed 12 Aug 2023."},{"issue":"3","key":"924_CR25","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1002\/jmv.26614","volume":"93","author":"HE Yun","year":"2021","unstructured":"Yun HE, Ryu BY, Choe YJ. Impact of social distancing on incidence of vaccine-preventable diseases South Korea. J Med Virol. 2021;93(3):1814\u20136. https:\/\/doi.org\/10.1002\/jmv.26614.","journal-title":"J Med Virol"},{"issue":"4","key":"924_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28745","volume":"95","author":"YC Chen","year":"2023","unstructured":"Chen YC, Ho CH, Liu TH, et\u00a0al. Long-term risk of herpes zoster following COVID-19: a retrospective cohort study of 2 442 686 patients. J Med Virol. 2023;95(4):e28745. https:\/\/doi.org\/10.1002\/jmv.28745.","journal-title":"J Med Virol"},{"issue":"5","key":"924_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac118","volume":"9","author":"A Bhavsar","year":"2022","unstructured":"Bhavsar A, Lonnet G, Wang C, et\u00a0al. Increased risk of herpes zoster in adults \u226550 years old diagnosed with COVID-19 in the United States. Open Forum Infect Dis. 2022;9(5):ofac118. https:\/\/doi.org\/10.1093\/ofid\/ofac118.","journal-title":"Open Forum Infect Dis"},{"key":"924_CR28","unstructured":"L\u00f3pez-Lacort M, Correcher-Mart\u00ednez E, Mu\u00f1oz-Quiles C, D\u00edez-Domingo J, Orrico A. Risk of herpes zoster in individuals diagnosed with SARS-CoV2 infection in the Valencia region of Spain: a retrospective cohort population-based study. Abstract P2443 and poster presented at the 33rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 15\u201318 April 2023, Copenhagen Denmark. Available at https:\/\/elibrary.escmid.org\/?search%5Bfrom%5D=0&search%5Bquery%5D=Lo%C2%B4pez-Lacort&search%5Bdate%5D=&tab=docs#results. Accessed 20 Feb 2024."},{"issue":"12","key":"924_CR29","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1056\/NEJMoa2110475","volume":"385","author":"N Barda","year":"2021","unstructured":"Barda N, Dagan N, Ben-Shlomo Y, et\u00a0al. Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N Engl J Med. 2021;385(12):1078\u201390. https:\/\/doi.org\/10.1056\/NEJMoa2110475.","journal-title":"N Engl J Med"},{"key":"924_CR30","doi-asserted-by":"publisher","unstructured":"Correction to \"Long-term risk of herpes zoster following Covid-19: a retrospective cohort study of 2 442 686 patients\". J Med Virol. 2023;95(7):e28944. https:\/\/doi.org\/10.1002\/jmv.28944.","DOI":"10.1002\/jmv.28944"},{"issue":"24","key":"924_CR31","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1056\/NEJMc2115045","volume":"385","author":"N Dagan","year":"2021","unstructured":"Dagan N, Barda N, Balicer RD. Adverse effects after BNT162b2 vaccine and SARS-CoV-2 infection, according to age and sex. N Engl J Med. 2021;385(24):2299. https:\/\/doi.org\/10.1056\/NEJMc2115045.","journal-title":"N Engl J Med"},{"key":"924_CR32","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s11845-021-02714-z","volume":"191","author":"J Katz","year":"2022","unstructured":"Katz J, Yue S, Xue W. Herpes simplex and herpes zoster viruses in COVID-19 patients. Ir J Med Sci. 2022;191:1093\u20137. https:\/\/doi.org\/10.1007\/s11845-021-02714-z.","journal-title":"Ir J Med Sci"},{"key":"924_CR33","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.ijid.2021.02.033","volume":"104","author":"CMF Maia","year":"2021","unstructured":"Maia CMF, Marques NP, de Lucena EHG, de Rezende LF, Martelli DRB, Martelli-J\u00fanior H. Increased number of herpes zoster cases in Brazil related to the COVID-19 pandemic. Int J Infect Dis. 2021;104:732\u20133. https:\/\/doi.org\/10.1016\/j.ijid.2021.02.033.","journal-title":"Int J Infect Dis"},{"issue":"5","key":"924_CR34","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.oooo.2021.12.133","volume":"133","author":"NP Marques","year":"2022","unstructured":"Marques NP, Maia CMF, Marques NCT, et\u00a0al. Continuous increase of herpes zoster cases in Brazil during the COVID-19 pandemic. Oral Surg Oral Med Oral Pathol Oral Radiol. 2022;133(5):612\u20134. https:\/\/doi.org\/10.1016\/j.oooo.2021.12.133.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"924_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2022.100393","volume":"21","author":"EYF Wan","year":"2022","unstructured":"Wan EYF, Chui CSL, Wang Y, et\u00a0al. Herpes zoster related hospitalization after inactivated (CoronaVac) and mRNA (BNT162b2) SARS-CoV-2 vaccination: a self-controlled case series and nested case-control study. Lancet Reg Health West Pac. 2022;21:100393. https:\/\/doi.org\/10.1016\/j.lanwpc.2022.100393.","journal-title":"Lancet Reg Health West Pac"},{"issue":"5","key":"924_CR36","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1080\/14760584.2022.2044799","volume":"21","author":"M Gringeri","year":"2022","unstructured":"Gringeri M, Battini V, Cammarata G, et\u00a0al. Herpes zoster and simplex reactivation following COVID-19 vaccination: new insights from a Vaccine Adverse Event Reporting System (VAERS) database analysis. Expert Rev Vaccines. 2022;21(5):675\u201384. https:\/\/doi.org\/10.1080\/14760584.2022.2044799.","journal-title":"Expert Rev Vaccines"},{"issue":"7","key":"924_CR37","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1001\/jamainternmed.2022.2109","volume":"182","author":"BA Dickerman","year":"2022","unstructured":"Dickerman BA, Madenci AL, Gerlovin H, et\u00a0al. Comparative safety of BNT162b2 and mRNA-1273 vaccines in a nationwide cohort of US veterans. JAMA Intern Med. 2022;182(7):739\u201346. https:\/\/doi.org\/10.1001\/jamainternmed.2022.2109.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"924_CR38","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.cmi.2021.09.018","volume":"28","author":"D Shasha","year":"2021","unstructured":"Shasha D, Bareket R, Sikron FH, et\u00a0al. Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine: historical cohort study. Clin Microbiol Infect. 2021;28(1):130\u20134. https:\/\/doi.org\/10.1016\/j.cmi.2021.09.018.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"924_CR39","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.jaad.2021.11.025","volume":"87","author":"M Birabaharan","year":"2022","unstructured":"Birabaharan M, Kaelber DC, Karris MY. Risk of herpes zoster reactivation after messenger RNA COVID-19 vaccination: a cohort study. J Am Acad Dermatol. 2022;87(3):649\u201351. https:\/\/doi.org\/10.1016\/j.jaad.2021.11.025.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"924_CR40","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1111\/jdv.18184","volume":"36","author":"M Hertel","year":"2022","unstructured":"Hertel M, Heiland M, Nahles S, et\u00a0al. Real-world evidence from over one million COVID-19 vaccinations is consistent with reactivation of the varicella-zoster virus. J Eur Acad Dermatol Venereol. 2022;36(8):1342\u20138. https:\/\/doi.org\/10.1111\/jdv.18184.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"924_CR41","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.42240","volume":"5","author":"I Akpandak","year":"2022","unstructured":"Akpandak I, Miller DC, Sun Y, Arnold BF, Kelly JD, Acharya NR. Assessment of herpes zoster risk among recipients of COVID-19 vaccine. JAMA Netw Open. 2022;5(11):e2242240. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.42240.","journal-title":"JAMA Netw Open"},{"key":"924_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2022.101549","volume":"26","author":"SA Patil","year":"2022","unstructured":"Patil SA, Dygert L, Galetta SL, Balcer LJ, Cohen EJ. Apparent lack of association of COVID-19 vaccination with herpes zoster. Am J Ophthalmol Case Rep. 2022;26:101549. https:\/\/doi.org\/10.1016\/j.ajoc.2022.101549.","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"2","key":"924_CR43","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jaad.2023.03.031","volume":"89","author":"IL Chen","year":"2023","unstructured":"Chen IL, Chiu HY. Association of herpes zoster with COVID-19 vaccination: a systematic review and meta-analysis. J Am Acad Dermatol. 2023;89(2):370\u20131. https:\/\/doi.org\/10.1016\/j.jaad.2023.03.031.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"924_CR44","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/14760584.2022.2036128","volume":"21","author":"CW Chu","year":"2022","unstructured":"Chu CW, Jiesisibieke ZL, Yang YP, Wu PC, Lin HL, Tung TH. Association of COVID-19 vaccination with herpes zoster: a systematic review and meta-analysis. Expert Rev Vaccines. 2022;21(5):601\u20138. https:\/\/doi.org\/10.1080\/14760584.2022.2036128.","journal-title":"Expert Rev Vaccines"},{"issue":"7","key":"924_CR45","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1111\/bcp.15280","volume":"88","author":"LH Pr\u00e9ta","year":"2022","unstructured":"Pr\u00e9ta LH, Contejean A, Salvo F, Treluyer JM, Charlier C, Chouchana L. Association study between herpes zoster reporting and mRNA COVID-19 vaccines (BNT162b2 and mRNA-1273). Br J Clin Pharmacol. 2022;88(7):3529\u201334. https:\/\/doi.org\/10.1111\/bcp.15280.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"924_CR46","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/bjd.20639","volume":"186","author":"A Catal\u00e0","year":"2022","unstructured":"Catal\u00e0 A, Mu\u00f1oz-Santos C, Galv\u00e1n-Casas C, et\u00a0al. Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases. Br J Dermatol. 2022;186(1):142\u201352. https:\/\/doi.org\/10.1111\/bjd.20639.","journal-title":"Br J Dermatol"},{"issue":"1","key":"924_CR47","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jaad.2021.09.002","volume":"86","author":"DE McMahon","year":"2022","unstructured":"McMahon DE, Kovarik CL, Damsky W, et\u00a0al. Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: a registry-based study. J Am Acad Dermatol. 2022;86(1):113\u201321. https:\/\/doi.org\/10.1016\/j.jaad.2021.09.002.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"924_CR48","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jaad.2021.03.092","volume":"85","author":"DE McMahon","year":"2021","unstructured":"McMahon DE, Amerson E, Rosenbach M, et\u00a0al. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol. 2021;85(1):46\u201355. https:\/\/doi.org\/10.1016\/j.jaad.2021.03.092.","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"924_CR49","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1111\/jocd.15209","volume":"21","author":"KF Cebeci","year":"2022","unstructured":"Cebeci KF, Sava\u015f Erdo\u011fan S, Akta\u015f ND, et\u00a0al. Cutaneous reactions after COVID-19 vaccination in Turkey: a multicenter study. J Cosmet Dermatol. 2022;21(9):3692\u2013703. https:\/\/doi.org\/10.1111\/jocd.15209.","journal-title":"J Cosmet Dermatol"},{"issue":"22","key":"924_CR50","doi-asserted-by":"publisher","first-page":"6828","DOI":"10.3390\/jcm11226828","volume":"11","author":"LY Huang","year":"2022","unstructured":"Huang LY, Chiang CC, Li YL, et\u00a0al. Corneal complications after COVID-19 vaccination: a systemic review. J Clin Med. 2022;11(22):6828. https:\/\/doi.org\/10.3390\/jcm11226828.","journal-title":"J Clin Med"},{"issue":"11","key":"924_CR51","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.3390\/vaccines10111879","volume":"10","author":"P Ichhpujani","year":"2022","unstructured":"Ichhpujani P, Parmar UPS, Duggal S, Kumar S. COVID-19 vaccine-associated ocular adverse effects: an overview. Vaccines (Basel). 2022;10(11):1879. https:\/\/doi.org\/10.3390\/vaccines10111879.","journal-title":"Vaccines (Basel)."},{"issue":"2","key":"924_CR52","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/wno.0000000000001537","volume":"42","author":"I Lotan","year":"2022","unstructured":"Lotan I, Lydston M, Levy M. Neuro-ophthalmological complications of the COVID-19 vaccines: a systematic review. J Neuroophthalmol. 2022;42(2):154\u201362. https:\/\/doi.org\/10.1097\/wno.0000000000001537.","journal-title":"J Neuroophthalmol"},{"issue":"6","key":"924_CR53","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1097\/ico.0000000000003246","volume":"42","author":"RB Singh","year":"2023","unstructured":"Singh RB, Parmar UPS, Ichhpujani P, Jeng BH, Jhanji V. Herpetic eye disease after SARS-CoV-2 vaccination: a CDC-VAERS database analysis. Cornea. 2023;42(6):731\u20138. https:\/\/doi.org\/10.1097\/ico.0000000000003246.","journal-title":"Cornea"},{"issue":"7","key":"924_CR54","doi-asserted-by":"publisher","first-page":"245","DOI":"10.15585\/mmwr.mm7007a4","volume":"70","author":"K Hong","year":"2021","unstructured":"Hong K, Zhou F, Tsai Y, et\u00a0al. Decline in receipt of vaccines by Medicare beneficiaries during the COVID-19 pandemic \u2014 United States, 2020. MMWR Morb Mortal Wkly Rep. 2021;70(7):245\u20139. https:\/\/doi.org\/10.15585\/mmwr.mm7007a4.","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"1","key":"924_CR55","doi-asserted-by":"publisher","first-page":"2027196","DOI":"10.1080\/21645515.2022.2027196","volume":"18","author":"D Curran","year":"2022","unstructured":"Curran D, La EM, Salem A, Singer D, Lecrenier N, Poston S. Modeled impact of the COVID-19 pandemic and associated reduction in adult vaccinations on herpes zoster in the United States. Hum Vaccin Immunother. 2022;18(1):2027196. https:\/\/doi.org\/10.1080\/21645515.2022.2027196.","journal-title":"Hum Vaccin Immunother"},{"key":"924_CR56","doi-asserted-by":"publisher","DOI":"10.1017\/s0950268821001333","volume":"149","author":"MD Maldonado","year":"2021","unstructured":"Maldonado MD, Romero-Aibar J, P\u00e9rez-San-Gregorio MA. COVID-19 pandemic as a risk factor for the reactivation of herpes viruses. Epidemiol Infect. 2021;149:e145. https:\/\/doi.org\/10.1017\/s0950268821001333.","journal-title":"Epidemiol Infect"},{"issue":"12","key":"924_CR57","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1111\/ijd.15240","volume":"59","author":"A Nofal","year":"2020","unstructured":"Nofal A, Fawzy MM, Sharaf El Deen SM, El-Hawary EE. Herpes zoster ophthalmicus in COVID-19 patients. Int J Dermatol. 2020;59(12):1545\u20136. https:\/\/doi.org\/10.1111\/ijd.15240.","journal-title":"Int J Dermatol"},{"issue":"18","key":"924_CR58","doi-asserted-by":"publisher","first-page":"674","DOI":"10.15585\/mmwr.mm7018e1","volume":"70","author":"MW Tenforde","year":"2021","unstructured":"Tenforde MW, Olson SM, Self WH, et\u00a0al. Effectiveness of Pfizer-BioNTech and Moderna vaccines against COVID-19 among hospitalized adults aged \u226565\u00a0years \u2014 United States, January\u2013March 2021. MMWR Morb Mortal Wkly Rep. 2021;70(18):674\u20139. https:\/\/doi.org\/10.15585\/mmwr.mm7018e1.","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"2","key":"924_CR59","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.cmi.2021.10.005","volume":"28","author":"T Fiolet","year":"2022","unstructured":"Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin Microbiol Infect. 2022;28(2):202\u201321. https:\/\/doi.org\/10.1016\/j.cmi.2021.10.005.","journal-title":"Clin Microbiol Infect"},{"key":"924_CR60","unstructured":"Centers for Disease Control and Prevention. Vaccination Coverage among Adults in the United States, National Health Interview Survey, 2021. Includes online Table 2 (Estimated proportion of adults aged \u226550 years who ever received herpes zoster vaccination, by age and race and ethnicity \u2014 National Health Interview Survey, United States, 2021). https:\/\/www.cdc.gov\/vaccines\/imz-managers\/coverage\/adultvaxview\/pubs-resources\/vaccination-coverage-adults-2021.html. Accessed 4 Dec 2023."},{"issue":"2","key":"924_CR61","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1080\/07853890.2019.1588470","volume":"51","author":"TM Doherty","year":"2019","unstructured":"Doherty TM, Del Giudice G, Maggi S. Adult vaccination as part of a healthy lifestyle: moving from medical intervention to health promotion. Ann Med. 2019;51(2):128\u201340. https:\/\/doi.org\/10.1080\/07853890.2019.1588470.","journal-title":"Ann Med"},{"issue":"1","key":"924_CR62","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/vaccines8010034","volume":"8","author":"DC Cassimos","year":"2020","unstructured":"Cassimos DC, Effraimidou E, Medic S, Konstantinidis T, Theodoridou M, Maltezou HC. Vaccination programs for adults in Europe, 2019. Vaccines (Basel). 2020;8(1):34. https:\/\/doi.org\/10.3390\/vaccines8010034.","journal-title":"Vaccines (Basel)"},{"key":"924_CR63","unstructured":"United Nations. WHO chief declares end to COVID-19 as a global health emergency. https:\/\/news.un.org\/en\/story\/2023\/05\/1136367. Accessed 26 May 2023."},{"issue":"39","key":"924_CR64","doi-asserted-by":"publisher","first-page":"5532","DOI":"10.1016\/j.vaccine.2021.08.044","volume":"39","author":"H Sell","year":"2021","unstructured":"Sell H, Assi A, Driedger SM, et\u00a0al. Continuity of routine immunization programs in Canada during the COVID-19 pandemic. Vaccine. 2021;39(39):5532\u20137. https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.044.","journal-title":"Vaccine"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-024-00924-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-024-00924-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-024-00924-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T02:07:40Z","timestamp":1711505260000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-024-00924-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["924"],"URL":"https:\/\/doi.org\/10.1007\/s40121-024-00924-3","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"27 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Raunak Parikh, Mitra Yousefi, Desmond Curran and Robyn Widenmaier are employees of GSK. Raunak\u00a0Parikh and Robyn\u00a0Widenmaier hold stock\/stock options in GSK.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}